Literature DB >> 20855874

IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation.

Mohammad Hasan Zaki1, Peter Vogel, Mathilde Body-Malapel, Mohamed Lamkanfi, Thirumala-Devi Kanneganti.   

Abstract

Colorectal cancer is a leading cause of cancer-related deaths worldwide. Chronic inflammation is recognized as a predisposing factor for the development of colon cancer, but the molecular mechanisms linking inflammation and tumorigenesis have remained elusive. Recent studies revealed a crucial role for the NOD-like receptor protein Nlrp3 in regulating inflammation through the assembly of proinflammatory protein complexes termed inflammasomes. However, its role in colorectal tumor formation remains unclear. In this study, we showed that mice deficient for Nlrp3 or the inflammasome effector caspase-1 were highly susceptible to azoxymethane/dextran sodium sulfate-induced inflammation and suffered from dramatically increased tumor burdens in the colon. This was a consequence of markedly reduced IL-18 levels in mice lacking components of the Nlrp3 inflammasome, which led to impaired production and activation of the tumor suppressors IFN-γ and STAT1, respectively. Thus, IL-18 production downstream of the Nlrp3 inflammasome is critically involved in protection against colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855874      PMCID: PMC3104023          DOI: 10.4049/jimmunol.1002046

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway.

Authors:  Joseph R Maxwell; Rajwardhan Yadav; Robert J Rossi; Carl E Ruby; Andrew D Weinberg; Hector L Aguila; Anthony T Vella
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

2.  Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis.

Authors:  Sirish K Ippagunta; David D Brand; Jiwen Luo; Kelli L Boyd; Christopher Calabrese; Rinke Stienstra; Frank L Van de Veerdonk; Mihai G Netea; Leo A B Joosten; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

3.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).

Authors:  T Osaki; W Hashimoto; A Gambotto; H Okamura; P D Robbins; M Kurimoto; M T Lotze; H Tahara
Journal:  Gene Ther       Date:  1999-05       Impact factor: 5.250

5.  Promotion of colorectal neoplasia in experimental murine ulcerative colitis.

Authors:  I Okayasu; T Ohkusa; K Kajiura; J Kanno; S Sakamoto
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

6.  Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma.

Authors:  P Hegardt; B Widegren; L Li; B Sjögren; C Kjellman; I Sur; H O Sjögren
Journal:  Cancer Immunol Immunother       Date:  2001-11       Impact factor: 6.968

Review 7.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

8.  The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.

Authors:  Brian Badgwell; Gregory B Lesinski; Cynthia Magro; Gerard Abood; Ayham Skaf; William Carson
Journal:  J Surg Res       Date:  2004-01       Impact factor: 2.192

Review 9.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

10.  IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanoma.

Authors:  Gregory B Lesinski; Brian Badgwell; Jason Zimmerer; Tim Crespin; Yan Hu; Gerard Abood; William E Carson
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

View more
  166 in total

Review 1.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 2.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

3.  Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer.

Authors:  Rajendra Karki; Bhesh Raj Sharma; Ein Lee; Balaji Banoth; R K Subbarao Malireddi; Parimal Samir; Shraddha Tuladhar; Harisankeerth Mummareddy; Amanda R Burton; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  JCI Insight       Date:  2020-06-18

Review 4.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

5.  The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis.

Authors:  Tere M Williams; Rachel A Leeth; Daniel E Rothschild; Sheryl L Coutermarsh-Ott; Dylan K McDaniel; Alysha E Simmons; Bettina Heid; Thomas E Cecere; Irving C Allen
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

Review 6.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

7.  Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.

Authors:  Yi Yang; Carol Inatsuka; Ekram Gad; Mary L Disis; Leanna J Standish; Nirmal Pugh; David S Pasco; Hailing Lu
Journal:  Innate Immun       Date:  2013-12-09       Impact factor: 2.680

Review 8.  Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function.

Authors:  Antero Salminen; Anu Kauppinen; Mikko Hiltunen; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2013-11-28       Impact factor: 9.261

9.  Differential expression of inflammasomes in lung cancer cell lines and tissues.

Authors:  Hui Kong; Yanli Wang; Xiaoning Zeng; Zailiang Wang; Hong Wang; Weiping Xie
Journal:  Tumour Biol       Date:  2015-04-25

Review 10.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.